batanopride has been researched along with Hypotension in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Findlay, B; Kaizer, L; Laberge, F; Latreille, J; Lofters, WS; Osoba, D; Pater, J; Rusthoven, J; Warr, D; Wilson, K | 1 |
Dombernowsky, P; Herrstedt, J; Jeppesen, BH | 1 |
2 trial(s) available for batanopride and Hypotension
Article | Year |
---|---|
A randomized, double-blinded study comparing six doses of batanopride (BMY-25801) with methylprednisolone in patients receiving moderately emetogenic chemotherapy.
Topics: Adolescent; Adult; Antiemetics; Antineoplastic Agents; Diarrhea; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart; Humans; Hypotension; Life Tables; Male; Methylprednisolone; Metoclopramide; Multivariate Analysis; Serotonin Antagonists; Treatment Outcome; Vomiting | 1991 |
Dose-limiting hypotension with the 5-HT3-antagonist batanopride (BMY-25801).
Topics: Adult; Aged; Antiemetics; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Humans; Hypotension; Male; Metoclopramide; Middle Aged | 1991 |